These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19106797)

  • 1. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH; Khalil AA
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence.
    Mascitelli L; Pezzetta F; Goldstein MR
    Arch Med Res; 2010 Nov; 41(8):649-50. PubMed ID: 21199735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management.
    Leitersdorf E
    Int J Clin Pract; 2002 Mar; 56(2):116-9. PubMed ID: 11926698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ezetimibe in the prevention of cardiovascular disease: where do we stand after ARBITER 6-HALTS.
    Howard WJ
    Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):295-300. PubMed ID: 20556890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of ezetimibe-based therapy in patients with dyslipidemia.
    Miura S; Saku K
    J Cardiol; 2008 Aug; 52(1):1-6. PubMed ID: 18639771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.
    Ahmed MH; Byrne CD
    Diabetes Obes Metab; 2010 Nov; 12(11):958-66. PubMed ID: 20880342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ezetimibe on atherosclerosis in preclinical models.
    Davis HR; Lowe RS; Neff DR
    Atherosclerosis; 2011 Apr; 215(2):266-78. PubMed ID: 21397230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibe.
    Ziajka PE; Reis M; Kreul S; King H
    Am J Cardiol; 2004 Mar; 93(6):779-80. PubMed ID: 15019893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of ezetimibe: do they really exist?
    Kalogirou M; Tsimihodimos V; Elisaf M
    Eur J Pharmacol; 2010 May; 633(1-3):62-70. PubMed ID: 20152830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 20. [The current debate on lowering LDL cholesterol with ezetimibe].
    Erdmann E
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1742. PubMed ID: 20812160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.